Ron Cohen
2012
In 2012, Ron Cohen earned a total compensation of $3.8M as President and Chief Executive Officer at Acorda Therapeutics, a 2% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $571,200 |
|---|---|
| Option Awards | $1,590,684 |
| Salary | $690,000 |
| Stock Awards | $988,125 |
| Other | $7,350 |
| Total | $3,847,359 |
Cohen received $1.6M in option awards, accounting for 41% of the total pay in 2012.
Cohen also received $571.2K in non-equity incentive plan, $690K in salary, $988.1K in stock awards and $7.4K in other compensation.
Rankings
In 2012, Ron Cohen's compensation ranked 1,729th out of 11,487 executives tracked by ExecPay. In other words, Cohen earned more than 84.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,729 out of 11,487 | 85th |
Division Manufacturing | 619 out of 4,253 | 85th |
Major group Chemicals And Allied Products | 142 out of 1,198 | 88th |
Industry group Drugs | 78 out of 920 | 92nd |
Industry Biological Products, Except Diagnostic Substances | 12 out of 160 | 93rd |
Source: SEC filing on April 30, 2015.
Cohen's colleagues
We found four more compensation records of executives who worked with Ron Cohen at Acorda Therapeutics in 2012.
News
Acorda Therapeutics CEO Ron Cohen's 2022 pay falls 40% to $984K
April 27, 2023
Acorda Therapeutics CEO Ron Cohen's 2021 pay rises 9% to $1.6M
April 28, 2022
Acorda Therapeutics CEO Ron Cohen's 2020 pay falls 26% to $1.5M
April 23, 2021
Acorda Therapeutics General Counsel Jane Wasman's 2019 pay jumps 67% to $2.4M
April 28, 2020
Acorda Therapeutics CEO Ron Cohen's 2018 pay rises 20% to $2.4M
April 26, 2019